Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Based on the provided information, "morphine + CP" refers to a combination of morphine with another substance abbreviated as "CP". However, the search results do not provide information about what "CP" might refer to in this context. Morphine itself is a non-synthetic narcotic analgesic with a high potential for abuse. It is one of the most effective drugs known for the relief of severe pain. Morphine acts directly on the central nervous system (CNS) to relieve pain by binding to the mu-opioid receptors within the central nervous system and the peripheral nervous system. It is used to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment when other pain medicines did not work well enough or cannot be tolerated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morphine + CP.